Literature DB >> 10629555

Survival of patients with HTLV-I-associated lymph node lesions.

K Ohshima1, J Suzumiya, K Sato, M Kanda, T Simazaki, C Kawasaki, S Haraoka, M Kikuchi.   

Abstract

Adult T-cell leukaemia/lymphoma (ATLL), is a malignant condition associated with human T-cell leukaemia virus type I (HTLV-I). Usually, although not uniformly, histopathological examination of the lymph nodes shows a pleomorphic type. In addition, some patients with pre-overt ATLL show a Hodgkin's disease-like morphology and lymph nodes in non-neoplastic carriers show features of lymphadenitis. To characterize further the clinicopathological features of HTLV-I-associated lymphadenopathy, the histopathological features of the lymph nodes of 289 patients were classified into five types: lymphadenitis ( n=14), Hodgkin's-like (Hodgkin's) ( n=18), pleomorphic (medium and large cells) ( n=219), pleomorphic small cell ( n=11), and anaplastic large cell (ALC) ( n=27). Survival data were analysed according to the histopathological features of the lymph nodes. The pleomorphic type, which showed typical features of ATLL, was associated with a highly aggressive course and an initially high mortality, followed by a rapid decrease in survival. This pattern was also observed in patients with the ALC type. All cases with lymphadenitis were still alive at the end of the study, while survival progressively decreased in the Hodgkin's type. The small cell type showed an initial rapid decrease in survival followed by a plateau. These results show that the survival trends of patients with pleomorphic and anaplastic lymph node lesions are similar to those with ATL lymphoma, while patients with the lymphadenitis type of lesion were considered to have a non-neoplatic status. There is at present no effective therapy for ATLL, but in the future, these classification and survival data might be useful for the selection of appropriate chemotherapeutic regimens for patients with ATLL. Copyright 1999 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10629555     DOI: 10.1002/(SICI)1096-9896(199912)189:4<539::AID-PATH465>3.0.CO;2-T

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  6 in total

1.  Adult T-cell leukemia/lymphoma with Epstein-Barr virus-positive Hodgkin-like cells.

Authors:  Girish Venkataraman; Jonathan Berkowitz; John C Morris; John E Janik; Mark A Raffeld; Stefania Pittaluga
Journal:  Hum Pathol       Date:  2011-02-11       Impact factor: 3.466

Review 2.  CD56-positive adult T-cell leukemia/lymphoma: a case report and a review of the literature.

Authors:  Kei-Ji Sugimoto; Asami Shimada; Mutsumi Wakabayashi; Yasunobu Sekiguchi; Noriko Nakamura; Tomohiro Sawada; Yasunori Ota; Norio Komatsu; Masaaki Noguchi
Journal:  Med Mol Morphol       Date:  2014-03-28       Impact factor: 2.309

Review 3.  Microenvironment of adult T-cell leukemia/lymphoma-associated nodal lesions.

Authors:  Koichi Ohshima; Daisuke Niino; Kennosuke Karube
Journal:  Int J Hematol       Date:  2014-01-31       Impact factor: 2.490

Review 4.  Incidence of adult T-cell leukemia/lymphoma in nonendemic areas.

Authors:  Noriaki Yoshida; Dai Chihara
Journal:  Curr Treat Options Oncol       Date:  2015-02

5.  Dermatopathic reaction of lymph nodes in HTLV-1 carriers: a spectrum of reactive and neoplastic lesions.

Authors:  Shigeki Chinen; Takuya Miyagi; Yoshiya Murakami; Mitsuyoshi Takatori; Shugo Sakihama; Iwao Nakazato; Yoshiyuki Kariya; Sayaka Yamaguchi; Kenzo Takahashi; Kennosuke Karube
Journal:  Histopathology       Date:  2020-06-18       Impact factor: 5.087

6.  Clinical and cytopathological characteristics of HTLV-1+ hodgkin lymphoma.

Authors:  Katsumi Kobata; Shoichi Kimura; Yasuhito Mihashi; Hiromi Iwasaki; Shuichi Nonaka; Shinji Matsumoto; Yasushi Takamatsu; Ilseung Choi; Shigeto Kawauchi; Kenji Ishitsuka; Morishige Takeshita
Journal:  Cancer Med       Date:  2020-06-28       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.